HIV care support for women who inject drugs
Part of Infections, Women’s health & pregnancy clinical trials.
This study tests a program to help women living with HIV who also inject drugs stay engaged in their HIV care. It aims to reduce stigma and improve health outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have received an HIV-positive diagnosis and are registered in the national medical system.
- Your HIV transmission is linked to injection drug use, or you have a documented history of injection drug use at a clinic visit.
- You are able to provide informed consent at the time of enrollment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a stigma-reducing support program to help women living with HIV and serious mental illness stay adherent to HIV treatment. It focuses on sustaining viral suppression by addressing stigma that can make care harder, and it involves family and community leaders as part of the approach.
This study tests whether getting HIV care through a community program is as helpful as going to a clinic for people who just found out they have HIV. It looks at how well they stay in care and take their medicine.
This study tests ways to help people living with HIV in Indonesia stay engaged in their care. It may help you if you want extra support to keep up with your appointments and treatment.
This study tests a low-barrier, mobile HIV care program designed with input from patients and other stakeholders to help people stay engaged in care and reach an undetectable viral load. It may help if you’re having trouble keeping regular HIV appointments or staying on treatment.
This study looks at ways to help minibus drivers get tested for HIV and use long-acting injectable medicine to prevent or treat HIV. It tests combining HIV self-testing with long-acting injectables to see if it improves health outcomes for drivers.
This study tests whether a program can reduce shame and stigma for people living with HIV who also have a substance use disorder. It may help you feel less judged and cope better, while supporting HIV care.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.